Clinical Trial Update: A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a two-step approach to allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies, aiming to enhance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Hematopoietic and Lymphoid Cell Neoplasm | Phase 2 | Status: COMPLETED